Release Date: 29/06/11 08:46 Summary: Managing Director's presentation to shareholders at EGM Price Sensitive: No Download Document 2.3MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling